Beneficial Ownership Report · SCHEDULE 13G/A
Freenome, Inc.
FRNMNASDAQEQUITYCurrent
Beneficial Ownership Report
Structured filing — SCHEDULE 13G/A
primary_doc.xml
Amendment · This filing reports the amendment as submitted.
Subject company
- Company
- Freenome, Inc.
- Company CIK
- 0002017526
- Street
- GENESIS MARINA, 3300 MARINA BLVD
- City
- BRISBANE
- State / country code
- CA
- Postal code
- 94005
Statement details
- Amendment number
- 1
- Security class
- Common Stock, par value $0.0001 per share
- Event date
- 09/30/2026
- Rule designation
- Rule 13d-1(c)
Reporting person 1
- Name
- Point72 Asset Management, L.P.
- Citizenship / organization
- DE
- Reporting person type
- PN
- Group designation
- b
- Aggregate amount owned
- 2,659,259.00
- Percent of class
- 2.5
- Sole voting power
- 0.00
- Shared voting power
- 2,659,259.00
- Sole dispositive power
- 0.00
- Shared dispositive power
- 2,659,259.00
- Aggregate excludes certain shares
- N
Reporting person 2
- Name
- Point72 Capital Advisors, Inc.
- Citizenship / organization
- DE
- Reporting person type
- CO
- Group designation
- b
- Aggregate amount owned
- 2,659,259.00
- Percent of class
- 2.5
- Sole voting power
- 0.00
- Shared voting power
- 2,659,259.00
- Sole dispositive power
- 0.00
- Shared dispositive power
- 2,659,259.00
- Aggregate excludes certain shares
- N
Reporting person 3
- Name
- Steven A. Cohen
- Citizenship / organization
- X1
- Reporting person type
- IN
- Group designation
- b
- Aggregate amount owned
- 2,659,259.00
- Percent of class
- 2.5
- Sole voting power
- 0.00
- Shared voting power
- 2,659,259.00
- Sole dispositive power
- 0.00
- Shared dispositive power
- 2,659,259.00
- Aggregate excludes certain shares
- N
Item 1
Issuer
Freenome, Inc.
Principal executive office address
Genesis Marina, 3300 Marina Blvd, Brisbane, CA 94005
Item 2
Citizenship
Point72 Asset Management is a Delaware limited partnership. Point72 Capital Advisors Inc. is a Delaware corporation. Mr. Cohen is a United States citizen.
Filing person
This statement is filed by: (i) Point72 Asset Management, L.P. ("Point72 Asset Management") with respect to the shares of common stock, par value $0.0001 per share ("Common Stock"), of Freenome, Inc. (f/k/a Perceptive Capital Solutions Corp) held by an investment fund it manages; (ii) Point72 Capital Advisors, Inc. ("Point72 Capital Advisors Inc.") with respect to the shares of Common Stock held by an investment fund managed by Point72 Asset Management; and (iii) Steven A. Cohen ("Mr. Cohen") with respect to the shares of Common Stock beneficially owned by Point72 Asset Management and Point72 Capital Advisors Inc. Cubist Systematic Strategies, LLC is a relying adviser on the Form ADV of Point72 Asset Management and acts as a sub-advisor with respect to a portion of the shares of Common Stock reported herein.
Principal business or residence address
The address of the principal business office of Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902.
Item 3
Not applicable indication
Y
Item 4
Percent of class
2.5%
Amount beneficially owned
The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on September 30, 2026. Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen own directly no shares of Common Stock. Pursuant to an investment management agreement, Point72 Asset Management maintains investment and voting power with respect to the securities held by an investment fund it manages. Point72 Capital Advisors Inc. is the general partner of Point72 Asset Management. Mr. Cohen controls each of Point72 Asset Management and Point72 Capital Advisors Inc. The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, the beneficial owner of the shares of Common Stock reported herein.
Sole voting power
The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on September 30, 2026.
Shared voting power
The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on September 30, 2026.
Sole dispositive power
The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on September 30, 2026.
Shared dispositive power
The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on September 30, 2026.
Item 5
Not applicable indication
N
Ownership of 5% or less
Y
Item 6
Not applicable indication
N
Ownership on behalf of another person
See Item 2(a).
Item 7
Not applicable indication
Y
Item 8
Not applicable indication
Y
Item 9
Not applicable indication
Y
Item 10
Not applicable indication
N
Certifications
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Signature 1
- Reporting person
- Point72 Asset Management, L.P.
- Signed
- /s/ Jason M. Colombo
- Title
- Jason M. Colombo, Authorized Person
- Date
- 11/16/2026
Signature 2
- Reporting person
- Point72 Capital Advisors, Inc.
- Signed
- /s/ Jason M. Colombo
- Title
- Jason M. Colombo, Authorized Person
- Date
- 11/16/2026
Signature 3
- Reporting person
- Steven A. Cohen
- Signed
- /s/ Jason M. Colombo
- Title
- Jason M. Colombo, Authorized Person
- Date
- 11/16/2026
Company context
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company’s proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome’s development of SimpleScreen™ CRC for colorectal cancer screening and a pipeline of tests for lung cancer and additional indications is designed to increase cancer detection among millions of at-risk individuals. For more information, visit www.freenome.com.
Current securities
Historical securities (1)
Recent company filings
- SCHEDULE 13G/A - filed by ADAR1 Capital Management, LLC regarding Freenome, Inc.Nov 16, 2026
- SCHEDULE 13G/A - filed by PERCEPTIVE ADVISORS LLC regarding Freenome, Inc.Nov 16, 2026
- SCHEDULE 13G/A - filed by Holocene Advisors, LP regarding Freenome, Inc.Nov 16, 2026
- SCHEDULE 13G/A - filed by One Fin Capital Management LP regarding Freenome, Inc.Nov 16, 2026
- SCHEDULE 13G/A - filed by RTW INVESTMENTS, LP regarding Freenome, Inc.Nov 16, 2026